-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-fullreport.pdf
February 01, 2018 - Timely Blood Culture for Children With Sepsis Syndrome
1
Timely Blood Culture for Children with Sepsis
Syndrome
Section 1. Basic Measure Information
1.A. Measure Name
Timely Blood Culture for Children with Sepsis Syndrome
1.B. Measure Number
0229
1.C. Measure Description
Please provide a non-technical …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-fullreport.pdf
May 01, 2018 - Timely Fluid Bolus for Children With Severe Sepsis or Septic Shock
1
Timely Fluid Bolus for Children with Severe Sepsis or
Septic Shock
Section 1. Basic Measure Information
1.A. Measure Name
Timely Fluid Bolus for Children with Severe Sepsis or Septic Shock
1.B. Measure Number
0231
1.C. Measure Descript…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-fullreport.pdf
June 01, 2018 - Documentation of Heart Rate During Fluid Resuscitation for Children With Severe Sepsis or Septic Shock
1
Documentation of Heart Rate During Fluid
Resuscitation for Children with Severe Sepsis or
Septic Shock
Section 1. Basic Measure Information
1.A. Measure Name
Documentation of Heart Rate During Fluid Resu…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-fullreport.pdf
April 02, 2018 - Timely Antibiotics for Children With Severe Sepsis or Septic Shock
1
Timely Antibiotics for Children with Severe Sepsis or
Septic Shock
Section 1. Basic Measure Information
1.A. Measure Name
Timely Antibiotics for Children with Severe Sepsis or Septic Shock
1.B. Measure Number
0230
1.C. Measure Descript…
-
effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1312.pdf
October 01, 2014 - Deep brain stimulation for neurological
movement disorders. Policy number I018-04.
[internet].
-
www.ahrq.gov/sites/default/files/publications/files/clabsicompanion.pdf
October 18, 2012 - 26)
Surgery unit (n=25)
Rehabilitation unit (n=12)
Orthopedics unit (n=9)
Obstetrics unit (n=6)
Neurological
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2021_Core.PDF
January 01, 2021 - EYE INFECTIONS WITH CC/MCC 526 0.01%
122: ACUTE MAJOR EYE INFECTIONS WITHOUT CC/MCC 261 0.00%
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2020_Core_V2.PDF
January 01, 2020 - EYE INFECTIONS WITH CC/MCC 468 0.01%
122: ACUTE MAJOR EYE INFECTIONS WITHOUT CC/MCC 253 0.00%
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2022_Core.PDF
January 01, 2022 - EYE INFECTIONS WITH CC/MCC 707 0.01%
122: ACUTE MAJOR EYE INFECTIONS WITHOUT CC/MCC 351 0.01%
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2017_Core_Weighted.PDF
January 01, 2017 - MAJOR EYE INFECTIONS W CC/MCC 2,665 0.01%
122: ACUTE MAJOR EYE INFECTIONS W/O CC/MCC 1,715 0.00%
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2019_Core_V2.PDF
January 01, 2019 - MAJOR EYE INFECTIONS W CC/MCC 624 0.01%
122: ACUTE MAJOR EYE INFECTIONS W/O CC/MCC 346 0.00%
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/nis/tools/stats/MaskedStats_NIS_2016_Core_Weighted.PDF
January 01, 2016 - MAJOR EYE INFECTIONS W CC/MCC 2,540 0.01%
122: ACUTE MAJOR EYE INFECTIONS W/O CC/MCC 2,060 0.01%
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_Core_Weighted_V2.PDF
January 01, 2019 - MAJOR EYE INFECTIONS W CC/MCC 2,976 0.01%
122: ACUTE MAJOR EYE INFECTIONS W/O CC/MCC 1,703 0.00%
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2016_Core.PDF
January 01, 2016 - July 23, 2018 18
Frequency Distribution for DRG_NOPOA
DRG_NoPOA Frequency
Percent
of Total
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2021_CORE.PDF
January 01, 2021 - INFECTIONS WITH CC/MCC 1,247 0.01%
122: ACUTE MAJOR EYE INFECTIONS WITHOUT CC/MCC 610 0.00%
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_CORE_V2.PDF
January 01, 2019 - MAJOR EYE INFECTIONS W CC/MCC 1,514 0.01%
122: ACUTE MAJOR EYE INFECTIONS W/O CC/MCC 798 0.00%
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2018_Core.PDF
January 01, 2018 - MAJOR EYE INFECTIONS W CC/MCC 1,387 0.01%
122: ACUTE MAJOR EYE INFECTIONS W/O CC/MCC 768 0.00%
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_V2.PDF
January 01, 2019 - MAJOR EYE INFECTIONS W CC/MCC 631 0.02%
122: ACUTE MAJOR EYE INFECTIONS W/O CC/MCC 543 0.02%
123: NEUROLOGICAL
-
hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2016_MaskedStats_Core.PDF
January 01, 2016 - MAJOR EYE INFECTIONS W CC/MCC 501 0.02%
122: ACUTE MAJOR EYE INFECTIONS W/O CC/MCC 617 0.02%
123: NEUROLOGICAL
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/6desD2XJCQKF8ZDPMS-NU_
July 01, 2005 - Childhood overweight and obesity’s health consequences include pulmonary,
orthopedic, gastroenterological, neurological